Friday, May 07, 2021 4:37:49 PM
On top of that, the news couldn't get the stock to cloase past 2 cents.
The IP is trash as we now just learned that Koos wants to revive the patent(s) he abandoned. If the IP was worth something, someone else would have come on in to grab it and issue their own patent. But no one did because ITS WORTHLESS JUNK!
ONPH is doing Koos a solid and we don't know the reason yet but we can be sure onph will end up doing nothing with the license.
Think about it. If the ip was worth something, Koos would have gone with an actual functional and reputable pharma had that pharma had any interest. No pharma has any interest.
Same situation with Ichim's companies. None of them have any significant deal with any large pharma at the moment.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM